Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestane.
Cancer Chemother Pharmacol
; 87(2): 277-287, 2021 02.
Article
in En
| MEDLINE
| ID: mdl-33515073
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Neoplastic Cells, Circulating
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Cancer Chemother Pharmacol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: